Atrinsic - 29 Year Stock Price History | PTIX

Historical daily share price chart and data for Atrinsic since 1996 adjusted for splits and dividends. The latest closing stock price for Atrinsic as of November 14, 2025 is 2.03.
  • The all-time high Atrinsic stock closing price was 1000000.00 on December 18, 1996.
  • The Atrinsic 52-week high stock price is 14.28, which is 603.4% above the current share price.
  • The Atrinsic 52-week low stock price is 1.83, which is 9.9% below the current share price.
  • The average Atrinsic stock price for the last 52 weeks is 4.30.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Atrinsic Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 3.8089 7.2730 11.1000 1.8900 2.0300 -70.41%
2024 12.7333 12.8800 25.4800 6.5730 6.8600 -50.51%
2023 23.2276 22.9600 33.0400 10.3502 13.8600 -38.13%
2022 42.6372 78.4000 81.2000 19.6000 22.4000 -71.12%
2021 157.9855 58.8000 392.0000 58.8000 77.5600 31.90%
2020 69.5725 78.9656 112.0000 58.8000 58.8000 -25.54%
2019 108.6559 128.8000 212.8000 78.4000 78.9656 -29.50%
2018 110.9818 123.2000 140.0000 70.0000 112.0000 -9.09%
2017 130.1354 280.0000 280.0000 59.3600 123.2000 -64.43%
2016 783.7158 173.1970 1731.9700 86.5985 346.3940 100.00%
2015 978.6456 1298.9800 2597.9500 173.1970 173.1970 -83.33%
2014 1615.1031 1472.1700 5195.9000 86.5985 1039.1800 -40.00%
2013 3097.8787 3463.9400 11084.6000 606.1890 1731.9700 -53.49%
2012 45078.4651 9439.2300 259795.0000 3290.7400 3723.7300 -51.14%
2011 872223.7662 1000000.0000 1000000.0000 7620.6600 7620.6600 -99.24%
2010 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2009 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2008 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2007 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2006 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2005 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2004 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2003 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2002 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2001 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1999 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1998 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1997 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.004B $0.000B
Protagenic Therapeutics, Inc. is a biotechnology company. It focused on the discovery, research and development of novel and naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. Protagenic Therapeutics, Inc., formerly known as Atrinsic, Inc., is based in New York, United States.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $276.335B 19.50
Amgen (AMGN) United States $181.328B 15.40
Gilead Sciences (GILD) United States $155.110B 15.26
Vertex Pharmaceuticals (VRTX) United States $110.913B 28.55
GSK (GSK) United Kingdom $95.795B 10.65
Bristol Myers Squibb (BMY) United States $94.968B 7.11
Regeneron Pharmaceuticals (REGN) United States $72.886B 18.91
Alnylam Pharmaceuticals (ALNY) United States $59.340B 1952.87
CSL (CSLLY) Australia $57.093B 0.00
Argenex SE (ARGX) Netherlands $55.903B 69.42
Insmed (INSM) United States $41.209B 0.00
Novozymes (NVZMY) Denmark $30.168B 0.00
BioNTech SE (BNTX) Germany $24.789B 0.00
Biogen (BIIB) United States $24.580B 10.01
Royalty Pharma (RPRX) United States $22.605B 8.66
Incyte (INCY) United States $20.447B 19.58
Genmab (GNMSF) Denmark $20.087B 14.74
Genmab (GMAB) Denmark $19.429B 14.62
Illumina (ILMN) United States $18.438B 27.68
Roivant Sciences (ROIV) United Kingdom $13.856B 0.00
Revolution Medicines (RVMD) United States $13.097B 0.00
Exact Sciences (EXAS) United States $12.700B 352.79
Ascendis Pharma (ASND) Denmark $12.610B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $12.417B 23.10
Guardant Health (GH) United States $11.894B 0.00
Exelixis (EXEL) United States $11.167B 17.88
Avidity Biosciences (RNA) United States $10.668B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.514B 19.07
QIAGEN (QGEN) Netherlands $9.852B 18.70
Moderna (MRNA) United States $9.677B 0.00
Bio-Techne Corp (TECH) United States $9.252B 34.52
Abivax SA (ABVX) France $8.592B 0.00
Repligen (RGEN) United States $8.577B 91.79
Jazz Pharmaceuticals (JAZZ) Ireland $8.572B 33.43
Bio-Rad Laboratories (BIO.B) United States $8.481B 30.49
Halozyme Therapeutics (HALO) United States $8.235B 13.16
Cytokinetics (CYTK) United States $8.123B 0.00
Merus (MRUS) Netherlands $7.278B 0.00
Axsome Therapeutics (AXSM) United States $7.042B 0.00
Nuvalent (NUVL) United States $7.016B 0.00
Cidara Therapeutics (CDTX) United States $6.845B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.634B 0.00
Vaxcyte (PCVX) United States $6.374B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.231B 0.00
PTC Therapeutics (PTCT) United States $6.046B 8.21
Krystal Biotech (KRYS) United States $5.978B 30.91
Zealand Pharma (ZLDPF) Denmark $5.717B 5.79
Arrowhead Pharmaceuticals (ARWR) United States $5.705B 0.00
Legend Biotech (LEGN) United States $5.591B 0.00
Protagonist Therapeutics (PTGX) United States $5.289B 136.47
Arcellx (ACLX) United States $5.203B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.006B 0.00
TG Therapeutics (TGTX) United States $4.922B 11.15
Alkermes (ALKS) Ireland $4.795B 14.10
Cogent Biosciences (COGT) United States $4.775B 0.00
Kymera Therapeutics (KYMR) United States $4.672B 0.00
Praxis Precision Medicines (PRAX) United States $4.662B 0.00
Akero Therapeutics (AKRO) United States $4.466B 0.00
Viking Therapeutics (VKTX) United States $4.421B 0.00
Immunovant (IMVT) United States $4.161B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.064B 34.31
Ligand Pharmaceuticals (LGND) United States $3.953B 97.03
Celcuity (CELC) United States $3.932B 0.00
Anbio Biotechnology (NNNN) Germany $3.744B 0.00
Belite Bio (BLTE) United States $3.716B 0.00
ADMA Biologics Inc (ADMA) United States $3.703B 26.37
Mirum Pharmaceuticals (MIRM) United States $3.672B 0.00
Scholar Rock Holding (SRRK) United States $3.596B 0.00
Disc Medicine (IRON) United States $3.396B 0.00
Mineralys Therapeutics (MLYS) United States $3.233B 0.00
Ascentage Pharma Group - (AAPG) China $3.201B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.191B 0.00
Telix Pharmaceuticals (TLX) Australia $3.161B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.150B 0.00
CG Oncology (CGON) United States $3.127B 0.00
Tarsus Pharmaceuticals (TARS) United States $3.095B 0.00
Travere Therapeutics (TVTX) United States $3.087B 0.00
Arcutis Biotherapeutics (ARQT) United States $3.062B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $3.056B 89.60
Apogee Therapeutics (APGE) United States $3.020B 0.00
Amicus Therapeutics (FOLD) United States $2.925B 237.00
Jyong Biotech (MENS) Taiwan $2.904B 0.00
GRAIL (GRAL) United States $2.871B 0.00
IDEAYA Biosciences (IDYA) United States $2.818B 0.00
Viridian Therapeutics (VRDN) United States $2.746B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.630B 0.00
Apellis Pharmaceuticals (APLS) United States $2.572B 65.58
Denali Therapeutics (DNLI) United States $2.558B 0.00
Agios Pharmaceuticals (AGIO) United States $2.545B 0.00
Liquidia (LQDA) United States $2.439B 0.00
Zai Lab (ZLAB) China $2.431B 0.00
Edgewise Therapeutics (EWTX) United States $2.409B 0.00
Beam Therapeutics (BEAM) United States $2.204B 0.00
Arcus Biosciences (RCUS) United States $2.167B 0.00
Bavarian Nordic (BVNRY) Denmark $2.161B 5.86
Recursion Pharmaceuticals (RXRX) United States $2.155B 0.00
Adaptive Biotechnologies (ADPT) United States $2.153B 0.00
Structure Therapeutics (GPCR) United States $2.121B 0.00
ImmunityBio (IBRX) United States $2.049B 0.00
Terns Pharmaceuticals (TERN) United States $2.032B 0.00
Vericel (VCEL) United States $2.016B 166.08
Sarepta Therapeutics (SRPT) United States $1.971B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.960B 10.70
Mesoblast (MESO) Australia $1.895B 0.00
ANI Pharmaceuticals (ANIP) United States $1.888B 14.64
Zenas BioPharma (ZBIO) United States $1.879B 0.00
UniQure (QURE) Netherlands $1.861B 0.00
Spyre Therapeutics (SYRE) United States $1.823B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.811B 0.00
Vera Therapeutics (VERA) United States $1.809B 0.00
Janux Therapeutics (JANX) United States $1.761B 0.00
Dianthus Therapeutics (DNTH) United States $1.751B 0.00
Celldex Therapeutics (CLDX) United States $1.698B 0.00
Nuvation Bio (NUVB) United States $1.666B 0.00
Alvotech (ALVO) Luxembourg $1.655B 23.87
Sionna Therapeutics (SION) United States $1.651B 0.00
Twist Bioscience (TWST) United States $1.622B 0.00
Immunome (IMNM) United States $1.572B 0.00
Maze Therapeutics (MAZE) United States $1.565B 0.00
MannKind (MNKD) United States $1.554B 50.60
Stoke Therapeutics (STOK) United States $1.514B 39.57
Precigen (PGEN) United States $1.445B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.445B 0.00
Zymeworks (ZYME) United States $1.386B 0.00
Trevi Therapeutics (TRVI) United States $1.385B 0.00
NeoGenomics (NEO) United States $1.338B 0.00
Certara (CERT) United States $1.327B 24.50
Upstream Bio (UPB) United States $1.326B 0.00
Dynavax Technologies (DVAX) United States $1.299B 38.14
NovoCure (NVCR) Jersey $1.268B 0.00
Immatics (IMTX) Germany $1.240B 0.00
Pharvaris (PHVS) Netherlands $1.231B 0.00
Oric Pharmaceuticals (ORIC) United States $1.190B 0.00
CureVac (CVAC) Germany $1.185B 5.50
WAVE Life Sciences (WVE) Singapore $1.184B 0.00
Rapport Therapeutics (RAPP) United States $1.162B 0.00
Pharming Group (PHAR) Netherlands $1.152B 0.00
Inhibrx Biosciences (INBX) United States $1.146B 0.00
Novavax (NVAX) United States $1.133B 2.88
Mind Medicine (MindMed) (MNMD) United States $1.118B 0.00
MBX Biosciences (MBX) United States $1.113B 0.00
Urogen Pharma (URGN) United States $1.112B 0.00
AbCellera Biologics (ABCL) Canada $1.105B 0.00
Tango Therapeutics (TNGX) United States $1.100B 0.00
MiMedx (MDXG) United States $1.093B 19.42
Sana Biotechnology (SANA) United States $1.063B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $1.049B 0.00
Septerna (SEPN) United States $1.042B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.036B 0.00
Kodiak Sciences (KOD) United States $1.031B 0.00
Pharming Group (PHGUF) Netherlands $1.027B 153.00
Oculis Holding AG (OCS) Switzerland $1.027B 0.00
Pacira BioSciences (PCRX) United States $1.023B 11.71
Intellia Therapeutics (NTLA) United States $1.008B 0.00
Nanobiotix S.A - (NBTX) France $0.997B 0.00
Palvella Therapeutics (PVLA) United States $0.991B 0.00
Nurix Therapeutics (NRIX) United States $0.984B 0.00
Iovance Biotherapeutics (IOVA) United States $0.981B 0.00
Castle Biosciences (CSTL) United States $0.976B 133.80
Kura Oncology (KURA) United States $0.975B 0.00
Fortrea Holdings (FTRE) United States $0.962B 20.41
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.959B 0.00
AnaptysBio (ANAB) United States $0.936B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.935B 44.88
Oxford BioMedica (OXBDF) United Kingdom $0.922B 0.00
Rezolute (RZLT) United States $0.915B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.904B 0.00
BGM Group (BGM) China $0.902B 0.00
CorMedix Inc (CRMD) United States $0.886B 8.20
Biohaven (BHVN) United States $0.879B 0.00
Arbutus Biopharma (ABUS) United States $0.866B 0.00
Compass Therapeutics (CMPX) United States $0.859B 0.00
ArriVent BioPharma (AVBP) United States $0.854B 0.00
Tyra Biosciences (TYRA) United States $0.840B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $0.820B 0.00
Bicara Therapeutics (BCAX) United States $0.810B 0.00
LENZ Therapeutics (LENZ) United States $0.801B 0.00
Rapt Therapeutics (RAPT) United States $0.799B 0.00
Vir Biotechnology (VIR) United States $0.783B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.781B 0.00
Gyre Therapeutics (GYRE) United States $0.770B 99.88
Erasca (ERAS) United States $0.732B 0.00
GH Research (GHRS) Ireland $0.728B 0.00
Astria Therapeutics (ATXS) United States $0.718B 0.00
Geron (GERN) United States $0.715B 0.00
Replimune (REPL) United States $0.705B 0.00
Cytek Biosciences (CTKB) United States $0.703B 0.00
Arvinas (ARVN) United States $0.679B 0.00
Ventyx Biosciences (VTYX) United States $0.660B 0.00
MeiraGTx Holdings (MGTX) United States $0.659B 0.00
CytomX Therapeutics (CTMX) United States $0.657B 9.70
Corvus Pharmaceuticals (CRVS) United States $0.655B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Gossamer Bio (GOSS) United States $0.627B 0.00
Myriad Genetics (MYGN) United States $0.625B 0.00
Prime Medicine (PRME) United States $0.608B 0.00
MapLight Therapeutics (MPLT) United States $0.584B 0.00
Opthea (OPT) Australia $0.583B 0.00
REGENXBIO (RGNX) United States $0.583B 0.00
Olema Pharmaceuticals (OLMA) United States $0.577B 0.00
Alumis (ALMS) United States $0.574B 0.00
Inventiva S.A (IVA) France $0.557B 0.00
Niagen Bioscience (NAGE) United States $0.548B 42.94
Invivyd (IVVD) United States $0.548B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.541B 0.00
Prothena (PRTA) Ireland $0.535B 0.00
Emergent Biosolutions (EBS) United States $0.531B 5.11
Keros Therapeutics (KROS) United States $0.526B 11.21
Cullinan Therapeutics (CGEM) United States $0.505B 0.00
Verastem (VSTM) United States $0.504B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.491B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.487B 0.00
Monopar Therapeutics (MNPR) United States $0.481B 0.00
NovaBridge Biosciences (NBP) United States $0.478B 0.00
Fulcrum Therapeutics (FULC) United States $0.468B 0.00
Eton Pharmaceuticals (ETON) United States $0.454B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.450B 0.00
DBV Technologies S.A (DBVT) France $0.448B 0.00
Neumora Therapeutics (NMRA) United States $0.443B 0.00
EnGene Holdings (ENGN) Canada $0.437B 0.00
Absci (ABSI) United States $0.424B 0.00
Design Therapeutics (DSGN) United States $0.420B 0.00
Bright Minds Biosciences (DRUG) United States $0.408B 0.00
XOMA Royalty (XOMA) United States $0.404B 0.00
Kamada (KMDA) Israel $0.402B 19.42
PureTech Health (PRTC) United States $0.391B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.377B 0.00
Alto Neuroscience (ANRO) United States $0.376B 0.00
Ocugen (OCGN) United States $0.372B 0.00
Northwest Biotherapeutics (NWBO) United States $0.370B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.365B 0.00
Jade Biosciences (JBIO) United States $0.349B 0.00
Tectonic Therapeutic (TECX) United States $0.347B 0.00
Benitec Biopharma (BNTC) United States $0.345B 0.00
Aura Biosciences (AURA) United States $0.344B 0.00
Amarin (AMRN) Ireland $0.340B 0.00
Entrada Therapeutics (TRDA) United States $0.334B 0.00
AC Immune (ACIU) Switzerland $0.330B 0.00
Solid Biosciences (SLDB) United States $0.330B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.330B 0.00
Neurogene (NGNE) United States $0.325B 0.00
Annexon (ANNX) United States $0.324B 0.00
X4 Pharmaceuticals (XFOR) United States $0.320B 0.00
Palisade Bio (PALI) United States $0.319B 0.00
Anavex Life Sciences (AVXL) United States $0.313B 0.00
Contineum Therapeutics (CTNM) United States $0.311B 0.00
DiaMedica Therapeutics (DMAC) United States $0.309B 0.00
Kyverna Therapeutics (KYTX) United States $0.301B 0.00
Lifecore Biomedical (LFCR) United States $0.298B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.283B 0.00
BioAge Labs (BIOA) United States $0.280B 0.00
Allogene Therapeutics (ALLO) United States $0.276B 0.00
Prima BioMed (IMMP) Australia $0.272B 0.00
Zura Bio (ZURA) United States $0.265B 0.00
Foghorn Therapeutics (FHTX) United States $0.265B 0.00
Immuneering (IMRX) United States $0.264B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.258B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.257B 0.00
Candel Therapeutics (CADL) United States $0.255B 0.00
Editas Medicine (EDIT) United States $0.254B 0.00
Sagimet Biosciences (SGMT) United States $0.252B 0.00
Puma Biotechnology (PBYI) United States $0.246B 6.61
Abeona Therapeutics (ABEO) United States $0.241B 3.94
C4 Therapeutics (CCCC) United States $0.239B 0.00
Alpha Teknova (TKNO) United States $0.238B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.236B 0.00
Atea Pharmaceuticals (AVIR) United States $0.231B 0.00
Black Diamond Therapeutics (BDTX) United States $0.228B 11.14
Rani Therapeutics Holdings (RANI) United States $0.228B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.228B 0.00
Nautilus Biotechnology (NAUT) United States $0.227B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.222B 0.00
Cabaletta Bio (CABA) United States $0.222B 0.00
Tenaya Therapeutics (TNYA) United States $0.221B 0.00
Adherex Technologies (FENC) United States $0.221B 0.00
Voyager Therapeutics (VYGR) United States $0.219B 0.00
Adocia (ADOCY) France $0.216B 0.00
Aardvark Therapeutics (AARD) United States $0.215B 0.00
GENFIT S.A (GNFT) France $0.213B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.207B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.205B 0.00
Genelux (GNLX) United States $0.202B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.201B 0.00
Humacyte (HUMA) United States $0.195B 0.00
Cartesian Therapeutics (RNAC) United States $0.194B 0.00
CAMP4 Therapeutics (CAMP) United States $0.192B 0.00
Caribou Biosciences (CRBU) United States $0.186B 0.00
Crescent Biopharma (CBIO) United States $0.181B 0.00
SELLAS Life Sciences (SLS) United States $0.179B 0.00
Forte Biosciences (FBRX) United States $0.175B 0.00
Molecular Partners AG (MOLN) Switzerland $0.170B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.170B 0.00
MaxCyte (MXCT) United States $0.168B 0.00
Innate Pharma S.A (IPHA) France $0.168B 0.00
PepGen (PEPG) United States $0.155B 0.00
Nuvectis Pharma (NVCT) United States $0.154B 0.00
Seres Therapeutics (MCRB) United States $0.151B 0.00
Sangamo Therapeutics (SGMO) United States $0.150B 0.00
Codexis (CDXS) United States $0.149B 0.00
Agenus (AGEN) United States $0.148B 0.00
Compugen (CGEN) Israel $0.146B 0.00
Elicio Therapeutics (ELTX) United States $0.146B 0.00
Anika Therapeutics (ANIK) United States $0.144B 0.00
Coherus Oncology (CHRS) United States $0.144B 0.00
Cardiff Oncology (CRDF) United States $0.143B 0.00
Immix Biopharma (IMMX) United States $0.141B 0.00
Mersana Therapeutics (MRSN) United States $0.139B 0.00
Actuate Therapeutics (ACTU) United States $0.137B 0.00
Cognition Therapeutics (CGTX) United States $0.137B 0.00
Inovio Pharmaceuticals (INO) United States $0.137B 0.00
Spero Therapeutics (SPRO) United States $0.136B 0.00
Alector (ALEC) United States $0.135B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.135B 0.00
Scilex Holding (SCLX) United States $0.134B 0.00
Nkarta (NKTX) United States $0.133B 0.00
Opus Genetics (IRD) United States $0.130B 0.00
Climb Bio (CLYM) United States $0.130B 0.00
EXoZymes (EXOZ) United States $0.128B 0.00
Alpha Cognition (ACOG) Canada $0.124B 0.00
Entera Bio (ENTX) Israel $0.124B 0.00
Coya Therapeutics (COYA) United States $0.123B 0.00
VTv Therapeutics (VTVT) United States $0.121B 0.00
Shattuck Labs (STTK) United States $0.119B 0.00
BioHarvest Sciences (BHST) Canada $0.119B 0.00
Connect Biopharma Holdings (CNTB) United States $0.119B 0.00
VistaGen Therapeutics (VTGN) United States $0.117B 0.00
Greenwich LifeSciences (GLSI) United States $0.115B 0.00
Turn Therapeutics (TTRX) United States $0.112B 0.00
Seer (SEER) United States $0.112B 0.00
Fate Therapeutics (FATE) United States $0.111B 0.00
Starpharma Holdings (SPHRY) Australia $0.110B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.105B 0.00
TuHURA Biosciences (HURA) United States $0.105B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.105B 0.00
Citius Oncology (CTOR) United States $0.104B 0.00
Oncolytics Biotech (ONCY) Canada $0.104B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.104B 0.00
Pliant Therapeutics (PLRX) United States $0.103B 0.00
Kalaris Therapeutics (KLRS) United States $0.102B 0.00
Adicet Bio (ACET) United States $0.102B 0.00
Whitehawk Therapeutics (WHWK) United States $0.101B 0.00
Atara Biotherapeutics (ATRA) United States $0.099B 6.31
Instil Bio (TIL) United States $0.097B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.096B 0.00
Adverum Biotechnologies (ADVM) United States $0.095B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.094B 0.00
Quince Therapeutics (QNCX) United States $0.094B 0.00
Ovid Therapeutics (OVID) United States $0.093B 0.00
InflaRx (IFRX) Germany $0.091B 0.00
Biomea Fusion (BMEA) United States $0.091B 0.00
Chrome Holding (MEHCQ) United States $0.090B 0.00
Adagene (ADAG) China $0.086B 0.00
Clene (CLNN) United States $0.086B 0.00
Estrella Immunopharma (ESLA) United States $0.086B 0.00
OKYO Pharma (OKYO) $0.084B 0.00
BeyondSpring (BYSI) United States $0.084B 0.00
Tevogen Bio Holdings (TVGN) United States $0.082B 0.00
XBiotech (XBIT) United States $0.080B 0.00
Artiva Biotherapeutics (ARTV) United States $0.080B 0.00
Fortress Biotech (FBIO) United States $0.078B 0.00
Precision BioSciences (DTIL) United States $0.078B 0.00
Sutro Biopharma (STRO) United States $0.077B 0.00
Immunic (IMUX) United States $0.077B 0.00
ALX Oncology Holdings (ALXO) United States $0.075B 0.00
ATyr Pharma (ATYR) United States $0.074B 0.00
CervoMed (CRVO) United States $0.071B 0.00
ABVC BioPharma (ABVC) United States $0.071B 0.00
Repare Therapeutics (RPTX) Canada $0.071B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.070B 0.00
Oncobiologics (OTLK) United States $0.070B 0.00
Vor Biopharma (VOR) $0.069B 0.00
BioStem Technologies (BSEM) $0.067B 4.68
TScan Therapeutics (TCRX) United States $0.062B 0.00
Annovis Bio (ANVS) United States $0.062B 0.00
Equillium (EQ) United States $0.062B 0.00
MiNK Therapeutics (INKT) United States $0.059B 0.00
Adlai Nortye (ANL) Cayman Islands $0.058B 0.00
Spruce Biosciences (SPRB) United States $0.053B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
BioAtla (BCAB) United States $0.046B 0.00
Kezar Life Sciences (KZR) United States $0.045B 0.00
Werewolf Therapeutics (HOWL) United States $0.045B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.043B 0.00
CalciMedica (CALC) United States $0.043B 0.00
OnKure Therapeutics (OKUR) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
Senti Biosciences (SNTI) United States $0.042B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.042B 0.00
Skye Bioscience (SKYE) United States $0.042B 0.00
Genenta Science S.p.A (GNTA) Italy $0.042B 0.00
Celularity (CELU) United States $0.041B 0.00
Aligos Therapeutics (ALGS) United States $0.041B 0.00
Radiopharm Theranostics - (RADX) Australia $0.041B 0.00
TELA Bio (TELA) United States $0.040B 0.00
PDS Biotechnology (PDSB) United States $0.040B 0.00
Medicus Pharma (MDCX) United States $0.039B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
Tvardi Therapeutics (TVRD) United States $0.038B 0.00
INmune Bio (INMB) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
Generation Bio (GBIO) United States $0.037B 0.00
Galecto (GLTO) Denmark $0.036B 0.00
Hyperion DeFi (HYPD) United States $0.035B 0.00
Alterity Therapeutics - (ATHE) Australia $0.034B 0.00
SAB Biotherapeutics (SABS) United States $0.034B 0.00
Dyadic (DYAI) United States $0.033B 0.00
ImageneBio (IMA) United States $0.033B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.032B 0.00
Tenax Therapeutics (TENX) United States $0.032B 0.00
Elutia (ELUT) United States $0.032B 0.00
Pluri (PLUR) Israel $0.031B 0.00
Applied Therapeutics (APLT) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Femasys (FEMY) United States $0.029B 0.00
Rein Therapeutics (RNTX) United States $0.029B 0.00
Passage Bio (PASG) United States $0.028B 0.00
Quantum Biopharma (QNTM) Canada $0.028B 0.00
Boundless Bio (BOLD) United States $0.028B 0.00
RenovoRx (RNXT) United States $0.027B 0.00
Jasper Therapeutics (JSPR) United States $0.027B 0.00
Apollomics (APLM) United States $0.027B 0.00
Rallybio (RLYB) United States $0.027B 0.00
NextCure (NXTC) United States $0.026B 0.00
Q32 Bio (QTTB) United States $0.026B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.026B 0.00
Intensity Therapeutics (INTS) United States $0.026B 0.00
BioXcel Therapeutics (BTAI) United States $0.026B 0.00
IBio (IBIO) United States $0.026B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.025B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.024B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.024B 0.00
Exicure (XCUR) United States $0.024B 0.00
Lexaria Bioscience (LEXX) Canada $0.024B 0.00
Synaptogenix (TAOX) United States $0.023B 0.00
Tharimmune (THAR) United States $0.022B 0.00
Moleculin Biotech (MBRX) United States $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Promis Neurosciences (PMN) Canada $0.021B 0.00
Clearside Biomedical (CLSD) United States $0.020B 0.00
Synlogic (SYBX) United States $0.020B 0.00
FibroBiologics (FBLG) United States $0.019B 0.00
Cingulate (CING) United States $0.019B 0.00
Lisata Therapeutics (LSTA) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.018B 0.00
Athira Pharma (ATHA) United States $0.018B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.017B 0.00
Curis (CRIS) United States $0.017B 0.00
Allarity Therapeutics (ALLR) United States $0.017B 0.00
MetaVia (MTVA) United States $0.017B 0.00
NewcelX (NCEL) Switzerland $0.016B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.015B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
Longeveron (LGVN) United States $0.015B 0.00
Revelation Biosciences (REVB) United States $0.014B 0.00
Soligenix (SNGX) United States $0.014B 0.00
Chemomab Therapeutics (CMMB) Israel $0.014B 0.00
GeoVax Labs (GOVX) United States $0.013B 0.00
BioCardia (BCDA) United States $0.013B 0.00
Dogwood Therapeutics (DWTX) United States $0.013B 0.00
Edesa Biotech (EDSA) Canada $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.011B 0.00
Beyond Air (XAIR) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Cocrystal Pharma (COCP) United States $0.011B 0.00
Novogen (KZIA) Australia $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.010B 0.00
Acurx Pharmaceuticals (ACXP) $0.010B 0.00
Biofrontera (BFRI) United States $0.010B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Gelteq (GELS) Australia $0.009B 0.00
Purple Biotech (PPBT) Israel $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
Aprea Therapeutics (APRE) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Evogene (EVGN) Israel $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Bionano Genomics (BNGO) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
BRIACELL THERAP (BCTX) Canada $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Entero Therapeutics (ENTO) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
KALA BIO (KALA) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Black Titan (BTTC) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
GT Biopharma (GTBP) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Alps Group (ALPS) United States $0.003B 2.35
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Artelo Biosciences (ARTL) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
IO Biotech (IOBT) Denmark $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
YD Bio (YDES) $0.000B 0.00